Global Ankylosing Spondylitis Treatment Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 113

Published Date: 11 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Ankylosing Spondylitis Treatment Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Ankylosing Spondylitis Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Ankylosing Spondylitis Treatment Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Ankylosing Spondylitis Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Ankylosing Spondylitis Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Ankylosing Spondylitis Treatment Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ankylosing Spondylitis Treatment Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ankylosing Spondylitis Treatment Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Merck, Eisai, Novartis and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Ankylosing Spondylitis Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Non-steroidal Anti-inflammatory Drugs
    Inhibitor

Market segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
    Other

Market segment by players, this report covers
    Abbott
    Merck
    Eisai
    Novartis
    Pfizer
    Johson & Johson
    Abbive
    UCB
    Amgen
    Takeda
    Mitsubishi Tanabe
    Hisun Pharm
    Guojian Pharmaceutical
    Bio-Thera Solutions
    Maibo Pharma
    Celgen Pharm

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ankylosing Spondylitis Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ankylosing Spondylitis Treatment Drug, with revenue, gross margin and global market share of Ankylosing Spondylitis Treatment Drug from 2018 to 2023.
Chapter 3, the Ankylosing Spondylitis Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Ankylosing Spondylitis Treatment Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Ankylosing Spondylitis Treatment Drug.
Chapter 13, to describe Ankylosing Spondylitis Treatment Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Ankylosing Spondylitis Treatment Drug by Type
        1.3.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type in 2022
        1.3.3 Non-steroidal Anti-inflammatory Drugs
        1.3.4 Inhibitor
    1.4 Global Ankylosing Spondylitis Treatment Drug Market by Application
        1.4.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacy
        1.4.3 Retail Pharmacy
        1.4.4 Online Pharmacy
        1.4.5 Other
    1.5 Global Ankylosing Spondylitis Treatment Drug Market Size & Forecast
    1.6 Global Ankylosing Spondylitis Treatment Drug Market Size and Forecast by Region
        1.6.1 Global Ankylosing Spondylitis Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Ankylosing Spondylitis Treatment Drug Market Size by Region, (2018-2029)
        1.6.3 North America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2018-2029)
        1.6.4 Europe Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2018-2029)
        1.6.6 South America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.1.4 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.2.4 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 Eisai
        2.3.1 Eisai Details
        2.3.2 Eisai Major Business
        2.3.3 Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.3.4 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eisai Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.4.4 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.5.4 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Johson & Johson
        2.6.1 Johson & Johson Details
        2.6.2 Johson & Johson Major Business
        2.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.6.4 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Johson & Johson Recent Developments and Future Plans
    2.7 Abbive
        2.7.1 Abbive Details
        2.7.2 Abbive Major Business
        2.7.3 Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.7.4 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Abbive Recent Developments and Future Plans
    2.8 UCB
        2.8.1 UCB Details
        2.8.2 UCB Major Business
        2.8.3 UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.8.4 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 UCB Recent Developments and Future Plans
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.9.4 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Amgen Recent Developments and Future Plans
    2.10 Takeda
        2.10.1 Takeda Details
        2.10.2 Takeda Major Business
        2.10.3 Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.10.4 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Takeda Recent Developments and Future Plans
    2.11 Mitsubishi Tanabe
        2.11.1 Mitsubishi Tanabe Details
        2.11.2 Mitsubishi Tanabe Major Business
        2.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.11.4 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Mitsubishi Tanabe Recent Developments and Future Plans
    2.12 Hisun Pharm
        2.12.1 Hisun Pharm Details
        2.12.2 Hisun Pharm Major Business
        2.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.12.4 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Hisun Pharm Recent Developments and Future Plans
    2.13 Guojian Pharmaceutical
        2.13.1 Guojian Pharmaceutical Details
        2.13.2 Guojian Pharmaceutical Major Business
        2.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.13.4 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Guojian Pharmaceutical Recent Developments and Future Plans
    2.14 Bio-Thera Solutions
        2.14.1 Bio-Thera Solutions Details
        2.14.2 Bio-Thera Solutions Major Business
        2.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.14.4 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Bio-Thera Solutions Recent Developments and Future Plans
    2.15 Maibo Pharma
        2.15.1 Maibo Pharma Details
        2.15.2 Maibo Pharma Major Business
        2.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.15.4 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Maibo Pharma Recent Developments and Future Plans
    2.16 Celgen Pharm
        2.16.1 Celgen Pharm Details
        2.16.2 Celgen Pharm Major Business
        2.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.16.4 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Celgen Pharm Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Ankylosing Spondylitis Treatment Drug Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Ankylosing Spondylitis Treatment Drug by Company Revenue
        3.2.2 Top 3 Ankylosing Spondylitis Treatment Drug Players Market Share in 2022
        3.2.3 Top 6 Ankylosing Spondylitis Treatment Drug Players Market Share in 2022
    3.3 Ankylosing Spondylitis Treatment Drug Market: Overall Company Footprint Analysis
        3.3.1 Ankylosing Spondylitis Treatment Drug Market: Region Footprint
        3.3.2 Ankylosing Spondylitis Treatment Drug Market: Company Product Type Footprint
        3.3.3 Ankylosing Spondylitis Treatment Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Ankylosing Spondylitis Treatment Drug Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Ankylosing Spondylitis Treatment Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2023)
    5.2 Global Ankylosing Spondylitis Treatment Drug Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2029)
    6.2 North America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2029)
    6.3 North America Ankylosing Spondylitis Treatment Drug Market Size by Country
        6.3.1 North America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2029)
        6.3.2 United States Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        6.3.3 Canada Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        6.3.4 Mexico Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2029)
    7.2 Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2029)
    7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Country
        7.3.1 Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2029)
        7.3.2 Germany Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        7.3.3 France Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        7.3.5 Russia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        7.3.6 Italy Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region
        8.3.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2018-2029)
        8.3.2 China Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        8.3.3 Japan Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        8.3.4 South Korea Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        8.3.5 India Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        8.3.7 Australia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2029)
    9.2 South America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2029)
    9.3 South America Ankylosing Spondylitis Treatment Drug Market Size by Country
        9.3.1 South America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2029)
        9.3.2 Brazil Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        9.3.3 Argentina Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country
        10.3.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2029)
        10.3.2 Turkey Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)
        10.3.4 UAE Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Ankylosing Spondylitis Treatment Drug Market Drivers
    11.2 Ankylosing Spondylitis Treatment Drug Market Restraints
    11.3 Ankylosing Spondylitis Treatment Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Ankylosing Spondylitis Treatment Drug Industry Chain
    12.2 Ankylosing Spondylitis Treatment Drug Upstream Analysis
    12.3 Ankylosing Spondylitis Treatment Drug Midstream Analysis
    12.4 Ankylosing Spondylitis Treatment Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Abbott Company Information, Head Office, and Major Competitors
    Table 6. Abbott Major Business
    Table 7. Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 8. Abbott Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Abbott Recent Developments and Future Plans
    Table 10. Merck Company Information, Head Office, and Major Competitors
    Table 11. Merck Major Business
    Table 12. Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 13. Merck Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Merck Recent Developments and Future Plans
    Table 15. Eisai Company Information, Head Office, and Major Competitors
    Table 16. Eisai Major Business
    Table 17. Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 18. Eisai Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Eisai Recent Developments and Future Plans
    Table 20. Novartis Company Information, Head Office, and Major Competitors
    Table 21. Novartis Major Business
    Table 22. Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 23. Novartis Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Novartis Recent Developments and Future Plans
    Table 25. Pfizer Company Information, Head Office, and Major Competitors
    Table 26. Pfizer Major Business
    Table 27. Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 28. Pfizer Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Pfizer Recent Developments and Future Plans
    Table 30. Johson & Johson Company Information, Head Office, and Major Competitors
    Table 31. Johson & Johson Major Business
    Table 32. Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 33. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Johson & Johson Recent Developments and Future Plans
    Table 35. Abbive Company Information, Head Office, and Major Competitors
    Table 36. Abbive Major Business
    Table 37. Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 38. Abbive Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Abbive Recent Developments and Future Plans
    Table 40. UCB Company Information, Head Office, and Major Competitors
    Table 41. UCB Major Business
    Table 42. UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 43. UCB Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. UCB Recent Developments and Future Plans
    Table 45. Amgen Company Information, Head Office, and Major Competitors
    Table 46. Amgen Major Business
    Table 47. Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 48. Amgen Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Amgen Recent Developments and Future Plans
    Table 50. Takeda Company Information, Head Office, and Major Competitors
    Table 51. Takeda Major Business
    Table 52. Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 53. Takeda Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Takeda Recent Developments and Future Plans
    Table 55. Mitsubishi Tanabe Company Information, Head Office, and Major Competitors
    Table 56. Mitsubishi Tanabe Major Business
    Table 57. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 58. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Mitsubishi Tanabe Recent Developments and Future Plans
    Table 60. Hisun Pharm Company Information, Head Office, and Major Competitors
    Table 61. Hisun Pharm Major Business
    Table 62. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 63. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Hisun Pharm Recent Developments and Future Plans
    Table 65. Guojian Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 66. Guojian Pharmaceutical Major Business
    Table 67. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 68. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Guojian Pharmaceutical Recent Developments and Future Plans
    Table 70. Bio-Thera Solutions Company Information, Head Office, and Major Competitors
    Table 71. Bio-Thera Solutions Major Business
    Table 72. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 73. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Bio-Thera Solutions Recent Developments and Future Plans
    Table 75. Maibo Pharma Company Information, Head Office, and Major Competitors
    Table 76. Maibo Pharma Major Business
    Table 77. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 78. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Maibo Pharma Recent Developments and Future Plans
    Table 80. Celgen Pharm Company Information, Head Office, and Major Competitors
    Table 81. Celgen Pharm Major Business
    Table 82. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 83. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Celgen Pharm Recent Developments and Future Plans
    Table 85. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Players (2018-2023)
    Table 86. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players (2018-2023)
    Table 87. Breakdown of Ankylosing Spondylitis Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Ankylosing Spondylitis Treatment Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 89. Head Office of Key Ankylosing Spondylitis Treatment Drug Players
    Table 90. Ankylosing Spondylitis Treatment Drug Market: Company Product Type Footprint
    Table 91. Ankylosing Spondylitis Treatment Drug Market: Company Product Application Footprint
    Table 92. Ankylosing Spondylitis Treatment Drug New Market Entrants and Barriers to Market Entry
    Table 93. Ankylosing Spondylitis Treatment Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Ankylosing Spondylitis Treatment Drug Consumption Value (USD Million) by Type (2018-2023)
    Table 95. Global Ankylosing Spondylitis Treatment Drug Consumption Value Share by Type (2018-2023)
    Table 96. Global Ankylosing Spondylitis Treatment Drug Consumption Value Forecast by Type (2024-2029)
    Table 97. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023)
    Table 98. Global Ankylosing Spondylitis Treatment Drug Consumption Value Forecast by Application (2024-2029)
    Table 99. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 100. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 101. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 104. North America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 105. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 108. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 109. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 112. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 113. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 114. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 115. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 116. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 117. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 118. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 119. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 120. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 121. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. South America Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 125. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 126. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 128. Middle East & Africa Ankylosing Spondylitis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 129. Ankylosing Spondylitis Treatment Drug Raw Material
    Table 130. Key Suppliers of Ankylosing Spondylitis Treatment Drug Raw Materials
List of Figures
    Figure 1. Ankylosing Spondylitis Treatment Drug Picture
    Figure 2. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type in 2022
    Figure 4. Non-steroidal Anti-inflammatory Drugs
    Figure 5. Inhibitor
    Figure 6. Global Ankylosing Spondylitis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Pharmacy Picture
    Figure 9. Retail Pharmacy Picture
    Figure 10. Online Pharmacy Picture
    Figure 11. Other Picture
    Figure 12. Global Ankylosing Spondylitis Treatment Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Ankylosing Spondylitis Treatment Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Ankylosing Spondylitis Treatment Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Region in 2022
    Figure 17. North America Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players in 2022
    Figure 23. Ankylosing Spondylitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Ankylosing Spondylitis Treatment Drug Market Share in 2022
    Figure 25. Global Top 6 Players Ankylosing Spondylitis Treatment Drug Market Share in 2022
    Figure 26. Global Ankylosing Spondylitis Treatment Drug Consumption Value Share by Type (2018-2023)
    Figure 27. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Type (2024-2029)
    Figure 28. Global Ankylosing Spondylitis Treatment Drug Consumption Value Share by Application (2018-2023)
    Figure 29. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Application (2024-2029)
    Figure 30. North America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Ankylosing Spondylitis Treatment Drug Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Ankylosing Spondylitis Treatment Drug Consumption Value (2018-2029) & (USD Million)
    Figure 64. Ankylosing Spondylitis Treatment Drug Market Drivers
    Figure 65. Ankylosing Spondylitis Treatment Drug Market Restraints
    Figure 66. Ankylosing Spondylitis Treatment Drug Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Ankylosing Spondylitis Treatment Drug in 2022
    Figure 69. Manufacturing Process Analysis of Ankylosing Spondylitis Treatment Drug
    Figure 70. Ankylosing Spondylitis Treatment Drug Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Merck
Eisai
Novartis
Pfizer
Johson & Johson
Abbive
UCB
Amgen
Takeda
Mitsubishi Tanabe
Hisun Pharm
Guojian Pharmaceutical
Bio-Thera Solutions
Maibo Pharma
Celgen Pharm

Related Reports

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2023-2029

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2023-2029

date 01 Feb 2023

date Pharma & Healthcare

The global Ankylosing Spondylitis Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Ankylosing Spondylitis Treatment Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Ankylosing Spondylitis Treatment Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ankylosing Spondylitis Treatment Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2024-2030

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Ankylosing Spondylitis Treatment Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Ankylosing Spondylitis Treatment Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>